Mediworth Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.45 M
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 95.56%
- Ebitda 93.59%
- Net Worth -0.04%
- Total Assets -0.04%
About Mediworth Lifesciences
Mediworth Lifesciences Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2004 and has a history of 20 years and four months. Its registered office is in Chandigarh, Chandigarh.
The Corporate was formerly known as Veer Stone Crusher Privae Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Parampreet Sekhon and Paramveer Singh serve as directors at the Company.
Company Details
-
LocationChandigarh, Chandigarh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233CH2004PTC027538
-
Company No.
027538
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Oct 2004
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Mediworth Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parampreet Sekhon
|
Director | 09-Mar-2022 | Current |
|
Paramveer Singh
|
Director | 01-Oct-2004 | Current |
Financial Performance of Mediworth Lifesciences.
Mediworth Lifesciences Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 95.56% increase in profit. The company's net worth dipped by a decrease of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediworth Lifesciences?
In 2021, Mediworth Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ssps Agrotech Private LimitedParamveer Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediworth Lifesciences?
Unlock and access historical data on people associated with Mediworth Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediworth Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediworth Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
